Gynecologic Oncology
June 2016 Volume 141, Supplement 1,
Knowledge about the HPV vaccine among employees at a tertiary cancer center: Room for improvement
K.R. Dahlstrom, E.M. Sturgis, R.A. DePinho, E. Hawk, G. Baum, E. Tamez, R. Bello, L.D. Stevens, L.M. Ramondetta
Objectives: Despite the availability of several US Food and Drug Administration–approved vaccines that prevent human papillomavirus (HPV)–related cancers, vaccination rates for girls and boys in the United States remain low. The aim of this study was to determine the knowledge and attitudes of employees at a tertiary cancer center toward HPV vaccination.

.
Resident physicians’ contribution to human papillomavirus vaccine uptake: Are residents offering the vaccine to eligible patients?
T. Zigras, H. Sauer, S. Kashani
Objectives: The goal of the study was to determine if resident physicians are vaccinating eligible patients with the human papillomavirus (HPV) vaccine. A comparison of the primary care specialties in the United States was undertaken to compare utilization of the vaccine, education during training, and foundation of knowledge. Family medicine, internal medicine, pediatrics, and obstetrics and gynecology were compared.